Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Vaxxas and CEPI Advance US$4.8 million (AU$7.2 million) Program for Needle-Free Thermostable mRNA Vaccines
10:00am, Wednesday, 22'nd Jan 2025
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today annou
After a Reset Year, Is Moderna Stock Poised for a Comeback?
07:31am, Wednesday, 22'nd Jan 2025
Biotechnology company Moderna Inc. NASDAQ: MRNA gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered acclaim as a
3-Stock Lunch: 3M, Moderna, & T-Mobile
03:10pm, Tuesday, 21'st Jan 2025
Eva Ados, ERshares COO and chief investment strategist, joins CNBC's 'Power Lunch' to share outlooks on three stocks.
Why Is Moderna Stock Trading Higher On Tuesday?
12:08pm, Tuesday, 21'st Jan 2025
Tuesday, Moderna Inc MRNA stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro.
Moderna Stock Jumps as Biotech Gets $590M From US To Develop Bird-Flu Vaccine
11:20am, Tuesday, 21'st Jan 2025
Shares of Moderna (MRNA) took off Tuesday when the biotech firm announced that the U.S. government has awarded it more than a half a billion dollars to develop a vaccine that can be used against bird
Underperforming Moderna Stock Boosted by Bird Flu Vaccine
10:53am, Tuesday, 21'st Jan 2025
Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded $590 million from the U.S. Health and Human Services Department to speed up th
Where Will Moderna Be in 3 Years?
10:15am, Tuesday, 21'st Jan 2025
As Moderna (MRNA 6.28%) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near future.
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab
10:10am, Monday, 20'th Jan 2025
MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for additional subtypes of pandemic influenza.
Despite Setbacks, Moderna Sees Opportunity In Avian Flu, Merck Partnership
01:41pm, Sunday, 19'th Jan 2025
Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028. Mer
Is Moderna Stock a Buy?
04:55am, Sunday, 19'th Jan 2025
Share prices of Moderna (MRNA 0.89%) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The biotech, renowned for its pioneering development of vaccines based on messenger
These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024
09:30am, Saturday, 18'th Jan 2025
Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy coupled with interest rate cuts by the Federal Reserve continues to fuel opti
Moderna is a 'trade' on Bird Flu vaccine pop, says Mizuho's Jared Holz
05:11pm, Friday, 17'th Jan 2025
Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.
Moderna Gets $590 Million of Federal Funding For Influenza Vaccines
04:44pm, Friday, 17'th Jan 2025
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said
Moderna Announces Updates on Pandemic Influenza Program
04:28pm, Friday, 17'th Jan 2025
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme
US awards Moderna $590 million for bird flu vaccine development
04:05pm, Friday, 17'th Jan 2025
The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in human
